Safety
Hypoglycemia on a GLP-1
These drugs almost never cause a low on their own. Add insulin or a sulfonylurea and a much smaller plate, and they do — and the symptoms look enough like a dozen other things that people treat the wrong problem.
This article is not for everyone taking these drugs. It is for the subset who also take insulin or a sulfonylurea, and for that group it is one of the more important pages here.
Why the drug alone rarely does it
GLP-1 receptor agonists stimulate insulin release glucose-dependently. The effect scales with how high your glucose is and switches off as it comes down toward normal. That is an unusually elegant property and it is why hypoglycemia is uncommon with these drugs used by themselves.
The problem is that they are frequently not used by themselves.
Insulin and sulfonylureas — glipizide, gliclazide, glimepiride — are not glucose-dependent. They lower glucose regardless of where it currently is. Add a drug that cuts food intake by 30–50% on top of a dose calibrated for how you used to eat, and the arithmetic goes one way.
The doses that need changing
This should be planned at the start, and frequently is not.
| Medication | Usual approach when starting a GLP-1 |
|---|---|
| Sulfonylurea | Often substantially reduced or stopped |
| Basal insulin | Commonly reduced |
| Mealtime insulin | Reduced, and reviewed as meals shrink |
| Metformin | Usually unchanged |
| SGLT2 inhibitor | Usually unchanged; own sick-day rules apply |
| DPP-4 inhibitor | Usually stopped — same pathway as the GLP-1 |
And again at each escalation. This is the part people miss. Intake keeps falling as the dose climbs, so a reduction that was right at 0.5 mg may be wrong at 1.7 mg. If nobody has mentioned this and you take insulin or a sulfonylurea, raise it before your next increase — the titration schedule is in what to do if you miss a dose.
Recognising it
Symptoms split into two groups, and the second is the dangerous one.
Adrenergic — the early warning: sweating, tremor, palpitations, hunger, anxiety, pallor.
Neuroglycopenic — the brain running short: confusion, difficulty concentrating, slurred speech, odd behaviour, drowsiness, and eventually seizure or loss of consciousness.
Two complications specific to this situation:
Hypoglycemia unawareness. Repeated lows blunt the early warning symptoms, so some people go straight to confusion with no adrenergic phase. If you have stopped noticing lows, that is a reason to see your diabetes team, not a sign things are going well.
The symptoms overlap with everything else here. Light-headedness on a GLP-1 is commonly over-treated blood pressure or dehydration — the dizziness piece covers telling them apart. If you take insulin or a sulfonylurea and cannot test, treat it as a low first. Being wrong in that direction costs you a glucose tablet. Being wrong the other way costs considerably more.
Which meter or continuous monitor to use, and the honest answer on whether a CGM is worth it without diabetes, is in the glucose monitor rankings.
Treating it
The rule of 15:
- 15 g of fast-acting carbohydrate — 4 glucose tablets, 150 ml of ordinary juice or non-diet soft drink, or a glucose gel.
- Wait 15 minutes.
- Recheck. If still below 70 mg/dL (3.9 mmol/L), repeat.
- Once recovered, eat something longer-acting with some protein, because whatever caused it has not gone away.
Not chocolate. Fat slows absorption of exactly the sugar you need fast. Not diet drinks, for obvious reasons.
Severe hypoglycemia — unable to treat yourself, unconscious, or seizing — needs glucagon and an ambulance. If you are at risk, you should have glucagon prescribed and somebody who lives with you should know where it is and how to use it. That conversation happens when you are well.
Alcohol, which is the combination that catches people
Alcohol suppresses the liver’s production of glucose. Combined with a sulfonylurea or insulin and a much smaller food intake, that is a well-established route to a serious low — and it can arrive 6–12 hours later, including overnight.
Worse: intoxication and hypoglycemia look alike. Confusion, slurred speech, unsteadiness — everyone present, including you, attributes them to the drink.
If you drink and take either of these agents: eat carbohydrate with alcohol, check before bed, and tell whoever you are with. The rest of the alcohol picture on this drug — including that far less of it goes considerably further now — is in drinking alcohol on a GLP-1.
Driving
Rules vary by country and the principle does not. Check your glucose before driving if you take insulin or a sulfonylurea, keep fast carbohydrate in the car, and do not drive with a glucose below your national threshold — commonly 5.0 mmol/L or 90 mg/dL as a driving minimum, above the treatment threshold for a reason.
If you have a low while driving: stop, remove the keys, move out of the driver’s seat, treat, and wait at least 45 minutes after recovery before driving again. Cognitive function takes longer to return than glucose does.
If you have type 1 diabetes
Everything above applies and the risk profile is different, because the danger is not only lows but ketoacidosis with a glucose that reads normal. Use in type 1 is off-label and belongs with a specialist team — GLP-1s and type 1 diabetes.
Sick days, and the other direction
When you cannot eat, insulin and sulfonylurea doses may need reducing further — but do not stop insulin entirely, particularly with type 1 diabetes, because that is how diabetic ketoacidosis happens. This is a same-day phone call rather than a unilateral decision, and it belongs in the plan agreed in sick day rules.
What to have in place
- A written plan for insulin and sulfonylurea doses when starting and at each escalation
- Glucose testing supplies, and agreement on when to test
- Fast carbohydrate in the house, the car and your bag — not chocolate
- Glucagon prescribed if you are at risk, and someone who knows how to use it
- A sick day plan for reduced intake
- An honest conversation about alcohol, if it is part of your life
Questions I get about this month
- Does Ozempic cause low blood sugar?
- Rarely on its own. GLP-1 receptor agonists stimulate insulin release in a glucose-dependent way, meaning the effect switches off as glucose falls toward normal, which is why hypoglycemia is uncommon with these drugs used alone. The risk appears in combination — insulin and sulfonylureas such as glipizide, gliclazide and glimepiride act regardless of your glucose level, and adding a drug that cuts food intake by a third to a half on top of them is the standard route to a low.
- Do I need to reduce my insulin or sulfonylurea when starting a GLP-1?
- Usually yes, and it should be planned rather than discovered. Prescribers commonly reduce sulfonylurea doses substantially or stop them when a GLP-1 is started, and reduce basal insulin as well. A further reduction is often needed during titration, because intake keeps falling as the dose climbs. If nobody has raised this with you and you take either drug, raise it yourself before your next dose increase.
- How do I treat a low blood sugar?
- Take 15 grams of fast-acting carbohydrate — four glucose tablets, 150 ml of ordinary fruit juice or non-diet soft drink, or a tube of glucose gel. Wait 15 minutes and recheck. If still below 70 mg/dL, repeat. Once recovered, eat something with longer-acting carbohydrate and protein, because the underlying cause has not gone away. Chocolate is a poor choice, because fat slows absorption of exactly the sugar you need quickly.
- How do I tell low blood sugar from low blood pressure on a GLP-1?
- Check a glucose if you can, because guessing has a poor record. Hypoglycemia tends to bring sweating, tremor, hunger, anxiety and confusion, and it improves within minutes of fast carbohydrate. Orthostatic hypotension is tied to changing position, comes on when you stand and eases when you sit back down. If you take insulin or a sulfonylurea and cannot test, treat it as a low first — the cost of being wrong in that direction is far lower.
Sources
- 01American Diabetes Association. Standards of Care in Diabetes — Glycemic Goals and Hypoglycemia.
- 02FDA prescribing information, Ozempic (semaglutide) injection.
- 03FDA prescribing information, Mounjaro (tirzepatide) injection.
- 04Marso SP et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). NEJM, 2016.
- 05Hendershot CS et al. Once-Weekly Semaglutide in Adults with Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry, 2025.
Elise Hall, MD
Board-certified internist in Los Angeles, twenty-one years in practice. She writes about GLP-1 medications and metabolic health for people who want the reasoning, not just the conclusion — and publishes her own year on one of these drugs alongside it.
Keep reading
Supplements
The Best Supplements for GLP-1 Hair Loss
The shedding starts two to four months after the loss speeds up, which is why almost nobody connects the two. Seven supplements ranked — and one of them interferes with the blood test that rules out a heart attack.
Supplements
Best Bone Health Supplements on a GLP-1
Bone is the tissue nobody thinks about until a wrist breaks. Rapid weight loss reduces bone mineral density, the effect is largest in exactly the people most likely to be prescribed these drugs, and none of it produces a symptom until it does.
Tools
The Best GLP-1 Apps, Ranked
I scored every tracker I could get my hands on against seven criteria that matter specifically on a GLP-1 — not generic calorie counting. Here is the ranking, the rubric behind it, and where my first choice falls short.